首页> 外文OA文献 >Population pharmacokinetics of a triple‐secured fibrinogen concentrate administered to afibrinogenaemic patients: Observed age‐ and body weight‐related differences and consequences for dose adjustment in children

【2h】

Population pharmacokinetics of a triple‐secured fibrinogen concentrate administered to afibrinogenaemic patients: Observed age‐ and body weight‐related differences and consequences for dose adjustment in children

机译：施用于阿伯因癌患者的三重固定纤维蛋白原浓缩物的人口药代动力学：观察到儿童剂量调整的年龄和体重相关差异和后果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Anne Bellon; Eliane Fuseau; Olivier Roumanie; Jennifer Lamazure; Wil Stevens; Amel Dahmane; Malika Barthez‐Toullec; Dominique Golly; Céline Henriet; Françoise Bridey;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Population pharmacokinetics of a triple‐secured fibrinogen concentrate administered to afibrinogenaemic patients: Observed age‐ and body weight‐related differences and consequences for dose adjustment in children [J] . Anne Bellon, Eliane Fuseau, Olivier Roumanie, British journal of clinical pharmacology . 2020,第2期

机译：施用于阿伯因癌患者的三重固定纤维蛋白原浓缩物的人口药代动力学：观察到儿童剂量调整的年龄和体重相关差异和后果
2. Population pharmacokinetics of a triple‐secured fibrinogen concentrate administered to afibrinogenaemic patients: Observed age‐ and body weight‐related differences and consequences for dose adjustment in children [J] . Bellon Anne, Fuseau Eliane, Roumanie Olivier, British Journal of Clinical Pharmacology . 2020,第2期

机译：施用于阿伯因癌患者的三重固定纤维蛋白原浓缩物的人口药代动力学：观察到儿童剂量调整的年龄和体重相关差异和后果
3. Clinical pharmacology, efficacy and safety study of a triple‐secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency [J] . Djambas Khayat Claudia, El Khorassani Mohamed, Lambert Thierry, Journal of thrombosis and haemostasis: JTH . 2019,第4期

机译：三重固定纤维蛋白原浓缩物在成人和青少年纤维蛋白原缺乏患者中的临床药理学，疗效和安全性研究
4. Clinical pharmacokinetic simulation/modeling as a tool for therapeutic drug monitoring and dose adjustment in special patient populations. [D] . Mohamed, Osama H. 2004

机译：临床药代动力学模拟/建模，作为特殊患者人群中治疗药物监测和剂量调整的工具。
5. Population pharmacokinetics of a triple‐secured fibrinogen concentrate administered to afibrinogenaemic patients: Observed age‐ and body weight‐related differences and consequences for dose adjustment in children [O] . Anne Bellon, Eliane Fuseau, Olivier Roumanie, 2020

机译：给予纤维蛋白原性病患者的三安全性纤维蛋白原浓缩物的群体药代动力学：观察到的年龄和体重相关差异以及儿童剂量调整的后果
6. Pharmacokinetics and Buccal Mucosal Concentrations of a 15 Milligram per Kilogram of Body Weight Total Dose of Liposomal Amphotericin B Administered as a Single Dose (15 mg/kg), Weekly Dose (7.5 mg/kg), or Daily Dose (1 mg/kg) in Peripheral Stem Cell Transplant Patients▿ [O] . Gubbins, Paul O., Amsden, Jarrett R., McConnell, Scott A., 2009

机译：每公斤体重15毫克脂质体两性霉素B总剂量的药代动力学和颊粘膜浓度为15毫克/千克，每周一次（7.5毫克/千克）或每日一次（1毫克/千克）干细胞移植患者中的应用▿

Population pharmacokinetics of a triple‐secured fibrinogen concentrate administered to afibrinogenaemic patients: Observed age‐ and body weight‐related differences and consequences for dose adjustment in children

著录项

引文网络

相似文献

相关主题

期刊订阅